Rabies Human Immunoglobulin (HRIG)

DRUG2 trials

Sponsors

Changchun BCHT Biotechnology Co.

Conditions

Rabies Virus Infection

Early Phase 1

Safety, Pharmacokinetics, and Pharmacodynamic Testing of Rabies mAb CBB 1

Changchun BCHT Biotechnology Co.Rabies Virus Infection

Start: 2023-04-30End: 2024-04-30Target: 152Updated: 2023-04-27

Phase 2

Rabies mAb CBB 1 Combination Vaccine in Healthy People With Antibody Neutralization Activity and Safety Phase Clinical Trials

Not yet recruitingNCT06548139

Changchun BCHT Biotechnology Co.Rabies Virus Infection

Start: 2024-07-31End: 2025-05-31Target: 120Updated: 2024-08-12